Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net income	$ 10,003	$ 7,293
Adjustments to reconcile net income to net cash provided by operations:
Depreciation and amortization	5,802	7,411
Stock-based compensation expense	1,185	1,495
Provision for deferred income taxes	2,917	(1,551)
Credit loss expense	6	137
Gain on sale of assets	(823)	(390)
Gain on insurance recovery	0	(874)
Amortization of original issue discount and debt issuance costs	69	131
Change in assets and liabilities:
Increase in receivables	(10,015)	(3,140)
Decrease in inventories	5,088	8,250
(Increase) decrease in other assets	(256)	39
Decrease in accounts payable	(522)	(306)
Decrease in accrued liabilities and other	(4,626)	(6,545)
Net cash provided by operating activities	8,828	11,950
Cash flows from investing activities:
Capital expenditures	(10,011)	(13,882)
Proceeds from divestitures	10,665	0
Proceeds from sale of property, plant and equipment	1,818	1,143
Other investing activities	2,946	0
Net cash provided by (used in) investing activities	5,418	(12,739)
Cash flows from financing activities:
Borrowings on lines of credit	0	52,561
Payments on lines of credit	0	(48,633)
Purchases of treasury stock	(10,810)	0
Proceeds from employee stock plans	0	17
Other financing activities	(865)	(3,356)
Net cash provided by (used in) financing activities	(11,675)	589
Effect of exchange rate changes on cash	26	(761)
Net increase (decrease) in cash, cash equivalents, and restricted cash	2,597	(961)
Cash, cash equivalents, and restricted cash at beginning of period	18,237	38,901
Cash, cash equivalents, and restricted cash at end of period	$ 20,834	$ 37,940